보험사 의료자문 남발? 제한적 실시해야!

글 내용 전체보기

• 

eBook: From Candidate to Clinic: PBPK Modeling and Other Strategies for Early Phase Success

글 내용 전체보기

Drug Prices in Ads: Senate Passes Amendment

글 내용 전체보기

FDA Draft Guidance for Waivers of REMS Requirement Draws Mixed Reactions

글 내용 전체보기

Shire Secures FDA Approval for HAE Drug Lanadelumab

글 내용 전체보기

• 

[글로리바이오텍] QuattroFlow Pump 무상점검 서비스

글 내용 전체보기

U.S. Senate Spending Bill Calls for TV Ad Price Disclosure of Drugs, Increases Spending on Alzheimer’s Research

글 내용 전체보기

Computer Program Can Predict How Cancer Tumors Will Respond to Drugs Before Dosing Begins

글 내용 전체보기

Rakuten Aspyrian Will Use $150 Million from Financing Round to Take Lead Candidate into Phase III

글 내용 전체보기

FDA Suggests Use of Placebo is Necessary Only in Certain Types of Oncology Trials

글 내용 전체보기

SEC Aims Insider Trading Charges at Former Sangamo Therapeutics Executive

글 내용 전체보기

National Strategy for Alzheimer’s Clinical Research to Launch this Fall

글 내용 전체보기

King Bio Recalls 32 Homeopathic Children’s Medicines Due to Microbial Contamination

글 내용 전체보기

August 24 Research Roundup: Stem Cells for Muscle, Autism, Dementia and More

글 내용 전체보기

The cardiovascular scene to shift by 2024 as next-gen drugs like Eliquis and Xarelto eclipse stalwarts

글 내용 전체보기

Drugmakers large and small score FDA nods in busy week of approvals

글 내용 전체보기

Shire eyes blockbuster sales with ‘best-in-class’ HAE drug Takhzyro

글 내용 전체보기

ESC: All eyes on Pfizer’s tafamidis as European heart confab kicks off

글 내용 전체보기

Bristol-Myers, AbbVie net FDA ‘breakthrough’ for myeloma drug Empliciti

글 내용 전체보기

Unraveling the mysteries of drug resistance in melanoma with CRISPR-Cas9

글 내용 전체보기

Senate approves $2B boost for NIH in $850B+ spending bill

글 내용 전체보기